Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,193 | 12,461 | 54,292 | 15,225 | 24,212 |
| Marketable Securities | 144,676 | 160,079 | 72,060 | 72,954 | 78,797 |
| Receivables | 1,664 | 1,061 | 742 | 1,006 | 1,202 |
| Other current assets | 0 | 128 | 128 | 128 | 128 |
| TOTAL | $157,769 | $175,186 | $129,366 | $90,813 | $105,922 |
| Non-Current Assets | |||||
| PPE Net | 10,681 | 11,829 | 12,183 | 12,622 | 12,743 |
| Investments And Advances | 27,446 | 0 | 12,601 | 12,601 | 12,601 |
| Intangibles | 81,118 | 83,011 | 83,011 | 123,809 | 123,809 |
| TOTAL | $119,245 | $94,840 | $107,795 | $149,032 | $149,153 |
| Total Assets | $277,014 | $270,026 | $237,161 | $239,845 | $255,075 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,385 | 6,459 | 10,646 | 6,403 | 8,274 |
| Other current liabilities | 1,090 | 1,029 | N/A | N/A | N/A |
| TOTAL | $11,541 | $10,396 | $14,627 | $8,235 | $11,881 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 12,001 | 12,001 | 12,001 |
| Deferred Revenues | 974 | 1,720 | 2,742 | 15 | 2,624 |
| Other Non-Current Liabilities | 9,769 | 9,576 | 10,424 | 10,211 | 10,014 |
| TOTAL | $27,401 | $27,212 | $40,061 | $64,219 | $67,408 |
| Total Liabilities | $38,942 | $37,608 | $54,688 | $72,454 | $79,289 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 55,070 | 62,090 | 55,027 |
| Common Shares | 878,191 | 876,288 | 876,108 | 876,049 | 873,841 |
| Retained earnings | -757,285 | -757,835 | -738,070 | -699,631 | -688,031 |
| Other shareholders' equity | -48,185 | -48,185 | -48,185 | -49,782 | -49,782 |
| TOTAL | $238,072 | $232,418 | $182,473 | $167,391 | $175,786 |
| Total Liabilities And Equity | $277,014 | $270,026 | $237,161 | $239,845 | $255,075 |